Join Team Titin at 2026 MDA Engage Events in Hershey and Chicago

Join Team Titin at 2026 MDA engage in Hershey July 18 and Chicago Sept 26

Team Titin is excited to share that we will be participating in two upcoming MDA Engage Community Education events in 2026: one in Hershey, Pennsylvania and one just outside Chicago, Illinois. These free, in-person events hosted by the Muscular Dystrophy Association bring together people living with neuromuscular disease, caregivers, clinicians, advocates, nonprofit organizations, and industry … Read more

Overview of Neuromuscular Breathing Weakness: What the Titin Community Should Know

Breathing weakness is an important topic for many people and families living with titinopathies. Changes in the TTN gene can cause a broad spectrum of muscle and heart disorders, and for some individuals, this can include weakness of the muscles used for breathing, coughing, and clearing secretions. Team Titin recently hosted the webinar “Overview of … Read more

Team Titin Partners with Citizen Health: Putting Your Data to Work for You – and for Research

At Team Titin, our mission is rooted in Connection, Advocacy, Care, and Research. We are excited to share a powerful new partnership that brings all four pillars together in a meaningful way. We are proud to partner with Citizen Health – a platform designed to support individuals and families living with rare and complex conditions … Read more

Team Titin Continues Support for Research on Dominant Titinopathy

We are pleased to announce continued funding of research led by genetic counselor and researcher Jennifer Roggenbuck, MS, CGC at Ohio State University focused on better understanding autosomal dominant titinopathies.

Team Titin mission and strategic goals

Image of a building with 4 pillars with the words connection, advocacy, care and research

With the start of the New Year it’s time to consider our goals and mission. Read more for details. Team Titin, Inc.’s mission is to serve those living with, caring for, or researching titin (TTN) related muscle and heart disorders. To achieve this mission, we focus on four key pillars: Connection, Advocacy, Care, and Research. … Read more

Team Titin in 2025: A Year of Impact – and Our Vision for 2026

Team Titin logo 2025 accomplishments & priorities for 2026 on a sparkling background

In 2025, Team Titin continued to grow, connect, and create change for people living with, caring for, and researching titin (TTN)–related muscle and heart conditions. Guided by our four mission pillars—Connection, Advocacy, Care, and Research—we made meaningful progress together. None of this would be possible without our families, donors, partners, clinicians, and researchers who believe … Read more

New partnership with Citizen Health

Team Titin and Citizen Health logos

Team Titin is thrilled to announce a new partnership with Citizen Health! Citizen Health is a platform designed specifically for individuals managing rare and complex conditions like TTN (titin) – related muscle and heart disorders. Their mission is simple: to empower patients to drive their care and research through their own health data and accelerate … Read more

Highlights from 2025 SciFam: Stronger Together

August 1- 4, 2025 • Philadelphia, PA Team Titin, together with our partners Cure CMD and A Foundation Building Strength for Nemaline Myopathy, proudly hosted the 2025 SciFam Conference – a four-day gathering for the congenital muscular dystrophy, nemaline myopathy, and titinopathy communities. More than 344 attendees – including affected individuals, families, caregivers, clinicians, researchers, … Read more

Research update from Isabelle Richard, PhD – July 2025

This is a July 2025 update on the research grant funding award to Dr. Isabelle Richard, PhD (Principal Investigator, Head of the Progressive Muscular Dystrophies Laboratory at Genethon), in collaboration with Dr Sonia Albini and Dr Edoardo Malfatti. Team Titin has funded $50,000 over two years to support the project, “Generation and characterization of skeletal … Read more

Attention All Stakeholders: The Scientific & Family Conference for Congenital Muscular Dystrophy, Nemaline Myopathy, and Titinopathy

Advancing Research and Care in the Congenital Muscular Dystrophies (CMD), Nemaline Myopathy, and Titinopathy – Join Us at the 2025 SciFam Conference (SciFam.info) April 15, 2025: Cure CMD, A Foundation Building Strength, and Team Titin are thrilled to announce the return of the highly-anticipated 2025 Scientific & Family (SciFam) Conference, taking place August 1–5, 2025 … Read more